Peptide Purity Standards, Explained: A Verification Bureau Breakdown

What Does a Purity Percentage Actually Measure?

When a vendor lists a peptide as '99% pure,' that figure comes from an analytical technique, most commonly high-performance liquid chromatography (HPLC). HPLC works by pushing a dissolved sample through a column packed with a stationary phase. Different molecules travel through the column at different speeds, producing a chromatogram: a graph of detector signal over time. The area under each peak represents a fraction of the total sample. Purity is calculated as the target compound's peak area divided by the sum of all peak areas, expressed as a percentage.

That calculation has a built-in limitation. HPLC measures relative peak area, not absolute mass. If two impurities happen to absorb UV light poorly at the detector's wavelength, their peaks will be underrepresented and the purity figure will look higher than it really is. This is why a single HPLC trace, on its own, is a necessary but not sufficient piece of evidence. The method parameters, including column type, mobile phase, gradient, and detection wavelength, all affect what the instrument can see.

A purity figure also says nothing about what the impurities are. A peptide could read 97% pure by HPLC while containing a structurally similar deletion sequence, a residual solvent, or an unrelated compound entirely. The purity number quantifies how much of the sample is the dominant peak; it does not identify or characterize everything else present.

Why Mass Spectrometry Is the Companion Test

Mass spectrometry (MS) answers the question HPLC cannot: is the dominant peak actually the compound the vendor claims it is? MS ionizes the sample and measures the mass-to-charge ratio of the resulting ions. Every peptide has a predictable molecular weight based on its amino acid sequence. If the measured mass matches the theoretical mass within accepted tolerance, that is strong evidence the correct sequence was synthesized.

The most common format in peptide quality control is electrospray ionization mass spectrometry (ESI-MS). A legitimate COA will show the theoretical molecular weight, the observed m/z values for one or more charge states, and the calculated mass derived from those values. If those numbers are absent or if only a single charge state is shown for a large peptide where multiple charge states are expected, that is a documentation gap worth flagging.

Mass spec confirms identity; HPLC quantifies purity. Together they form the standard two-test minimum for research-grade peptide documentation. Some labs also run tandem mass spectrometry (MS/MS) or amino acid analysis for higher-confidence identity confirmation, but those are less commonly included in standard commercial COAs. Their absence is not automatically a red flag, but their presence raises the evidentiary bar.

What a Legitimate COA Must Contain

A certificate of analysis is only as credible as the information it carries. At minimum, a verifiable COA should include: the compound name and sequence, the batch or lot number, the date of analysis, the name and contact information of the testing laboratory, the HPLC purity result with method conditions, the mass spectrometry result with observed and theoretical masses, and the analyst's signature or lab accreditation number. Missing any of these fields does not automatically mean the document is fabricated, but each gap reduces the chain of evidence.

The batch number is the single most important traceability element. It links the physical vial to a specific production run and, if the lab is legitimate, to records that can be independently requested. A vendor who cannot provide a batch number, or who provides the same batch number across products that were clearly produced at different times, is presenting documentation that cannot be traced. Batch numbers should also appear on the product label itself, matching the COA exactly.

Lab accreditation matters because it means a third party has audited the facility's methods and equipment. In the United States, ISO/IEC 17025 is the relevant standard for testing and calibration laboratories. A COA from an ISO 17025-accredited lab carries more weight than one from an unaccredited facility because the accreditation body has independently verified that the lab's results are reproducible and traceable to national measurement standards. Accreditation status for U.S. labs can be checked through the ILAC-recognized accreditation bodies, including A2LA and NVLAP.

• Compound name and full sequence
• Batch or lot number matching the product label
• Date of analysis
• Testing laboratory name, address, and accreditation number
• HPLC purity percentage with method parameters
• Mass spectrometry result: theoretical vs. observed mass
• Analyst signature or authorized signatory

How to Spot Fabricated or Recycled Documentation

Fabricated COAs follow recognizable patterns once you know what to look for. The most common tell is a COA that lacks a chromatogram image or shows a chromatogram with no axis labels, no retention time values, or a suspiciously clean baseline with a single perfect peak. Real HPLC chromatograms almost always show minor peaks, baseline noise, or solvent fronts. A perfectly flat baseline with one peak is a sign the image may have been generated rather than recorded.

Recycled COAs are a separate problem. A vendor may take a legitimate COA from one batch and attach it to a different product or a later batch that was never independently tested. Cross-referencing the batch number on the COA against the batch number printed on the vial label is the first check. The second is to contact the testing lab directly and ask whether they can confirm a result was issued for that batch number. Legitimate labs will confirm or deny this; a lab that cannot be reached or does not exist is a clear failure point.

Font inconsistencies, mismatched metadata in PDF file properties, and lab logos that do not match the lab's actual branding are secondary indicators of document manipulation. These are not definitive on their own, but they warrant further investigation. Some buyers use free PDF metadata viewers to check the creation date and software listed in the file properties against the date printed on the COA. A document that claims to have been issued in 2023 but whose PDF metadata shows it was created in 2025 has an unexplained discrepancy.

What Purity Standards Cannot Tell You

Even a fully verified, third-party COA with a 99% HPLC purity result and confirmed mass spectrometry leaves several questions unanswered. It does not confirm sterility. It does not test for endotoxins, which are bacterial cell-wall fragments that can cause serious inflammatory responses if introduced into the body. Endotoxin testing requires a separate assay, typically the Limulus Amebocyte Lysate (LAL) test, and most standard commercial COAs do not include it.

A COA also does not confirm that the compound in the vial matches what is on the label in terms of quantity. A vendor could ship a vial labeled as 5 mg that contains 3 mg of a 99%-pure peptide. Quantitative analysis, such as amino acid analysis or a calibrated HPLC method with an external standard, is needed to verify actual mass. This type of testing is less common in standard COAs but is increasingly offered by independent third-party testing services that buyers can commission separately.

Finally, purity documentation addresses the chemistry of the compound, not its regulatory status. Research peptides sold in the United States are not approved drugs. The FDA has approved specific branded pharmaceuticals containing peptide active ingredients, such as Wegovy and Ozempic (semaglutide) and Mounjaro and Zepbound (tirzepatide), but those approvals apply to those specific products manufactured under pharmaceutical-grade conditions, not to research-chemical versions of the same molecules. A high purity score on a COA does not confer any regulatory approval or imply safety for human use.